Serveur d'exploration Chloroquine - Exploration (Accueil)

Index « ISSN » - entrée « 1365-2133 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
1364-5528 < 1365-2133 < 1365-2141  Facettes :

List of bibliographic references indexed by 1365-2133

Number of relevant bibliographic references: 151.
[0-50] [0 - 20][0 - 50][50-70]
Ident.Authors (with country if any)Title
000421 (2019) A L Marano [États-Unis] ; J M Clarke [États-Unis] ; M A Morse [États-Unis] ; A. Shah [États-Unis] ; W. Barrow [États-Unis] ; M A Selim [États-Unis] ; R P Hall [États-Unis] ; A R Cardones [États-Unis]Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy.
000E01 (2016) I. Blanco [Espagne] ; D. Lipsker [France] ; B. Lara [Royaume-Uni] ; S. Janciauskiene [Allemagne]Neutrophilic panniculitis associated with alpha‐1‐antitrypsin deficiency: an update
000E22 (2016) F. Galimberti [États-Unis] ; Y. Li [États-Unis] ; A. P. Fernandez [États-Unis]Clinically amyopathic dermatomyositis: clinical features, response to medications and malignancy‐associated risk factors in a specific tertiary‐care‐centre cohort
000E26 (2016) British Society for Dermatopathology
000E27 (2016) British Photodermatology Group
000F23 (2015) G. Jeudy [France] ; S. Dalac-Rat [France] ; B. Bonniaud [France] ; A. Hervieu [France] ; T. Petrella [France] ; E. Collet [France] ; P. Vabres [France]Successful switch to dabrafenib after vemurafenib‐induced toxic epidermal necrolysis
000F25 (2015) B. C. Böckle [Autriche] ; N. T. Sepp [Autriche]Sex influences the clinical course of lupus erythematosus: a retrospective cohort study
000F43 (2015) Medical Dermatology Meeting abstracts
000F60 (2015) C. Saintes [France] ; M. Saint-Jean [France] ; J. J. Renaut [France] ; B. Dréno [France] ; G. Quéreux [France]Dramatic efficacy of brentuximab vedotin in two patients with epidermotropic cutaneous T‐cell lymphomas after treatment failure despite variable CD30 expression
000F70 (2015) Clinicopathological Cases
001078 (2014) Clinicopathological Cases
001080 (2014) British Society for Skin Care in Immunocompromised Individuals
001157 (2013) C. Hotz [France] ; L. Valeyrie-Allanore [France] ; C. Haddad [France] ; S. Bouvresse [France] ; N. Ortonne [France] ; T. A. Duong [France] ; S. Ingen-Housz-Oro [France] ; J. C. Roujeau [France] ; P. Wolkenstein [France] ; O. Chosidow [France]Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients
001170 (2013) A. Adam [France] ; L. Thomas [France] ; N. Bories [France] ; D. Zaharia [France] ; B. Balme [France] ; N. Freymond [France] ; S. Dalle [France]Sarcoidosis associated with vemurafenib
001177 (2013) F. Rongioletti [Italie] ; V. Merlo [Italie] ; S. Riva [Italie] ; E. Cozzani [Italie] ; E. Cinotti [Italie] ; G. Ghigliotti [Italie] ; A. Parodi [Italie] ; J. Kanitakis [France]Reticular erythematous mucinosis: a review of patients' characteristics, associated conditions, therapy and outcome in 25 cases
001195 (2013) A. Petit [France] ; O. E. DadzieMultisystemic diseases and ethnicity: a focus on lupus erythematosus, systemic sclerosis, sarcoidosis and Behçet disease
001198 (2013) Medical Dermatology Meeting, Royal College of Physicians, London, 10 January 2013
001202 (2013) E. J. Van Zuuren [Pays-Bas] ; Z. Fedorowicz [Pays-Bas]Lack of ‘appropriately assessed’ patient‐reported outcomes in randomized controlled trials assessing the effectiveness of interventions for rosacea
001236 (2013) Clinicopathological Cases
001336 (2012) M. Ziemer [Allemagne] ; S. H. Kardaun [Pays-Bas] ; Y. Liss [Allemagne] ; M. Mockenhaupt [Allemagne]Stevens–Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature
001359 (2012) C. Derancourt ; R. Theodose ; L. Deschamps ; B. Liautaud [France] ; E. Briand [France] ; S. Derancourt [France] ; N. Desbois ; A. Le Fleche Mateos [France]Primary cutaneous nocardiosis caused by Nocardia beijingensis
001386 (2012) R. Alghamdi ; C. Bejar ; M. Steff ; L. Deschamps [France] ; E. Marinho [France] ; B. Crickx ; V. DescampsIntravenous immunoglobulins as a treatment of interstitial granulomatous dermatitis with arthritis
001400 (2012) J. S. Wee [Royaume-Uni] ; P. J. Shirlaw [Royaume-Uni] ; S. J. Challacombe [Royaume-Uni] ; J. F. Setterfield [Royaume-Uni]Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients
001577 (2011) Bristol Cup Posters
001737 (2010) Clinicopathological Cases
001817 (2009) O. Inhoff [Allemagne] ; W. K. Peitsch [Allemagne] ; B. E. Paredes [Allemagne] ; S. Goerdt [Allemagne] ; M. Goebeler [Allemagne]Simvastatin‐induced amyopathic dermatomyositis
001999 (2008) R. E. Kalb [États-Unis] ; T. N. Helm [États-Unis] ; H. Sperry [États-Unis] ; C. Thakral [États-Unis] ; J. L. Abraham [États-Unis] ; E. Kanal [États-Unis]Gadolinium‐induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury
001A92 (2007) G. Morissette [Canada] ; L. Germain [Canada] ; F. Marceau [Canada]The antiwrinkle effect of topical concentrated 2‐dimethylaminoethanol involves a vacuolar cytopathology
001B77 (2007) British Society for Dermatopathology: Summary of Papers
001C82 (2006) Posters
001E22 (2005) K. A. Short [Royaume-Uni] ; E. M. Higgins [Royaume-Uni]Urticaria as a side‐effect of diphencyprone therapy for resistant viral warts
001E23 (2005) T. Yanagi [Japon] ; D. Sawamura [Japon] ; A. Shibaki [Japon] ; H. Shimizu [Japon]Treatment for poikilodermatous erythema of dermatomyositis with the pulsed dye laser
001E27 (2005) K. Breuer [Allemagne] ; R. Gutzmer [Allemagne] ; B. Völker [Allemagne] ; A. Kapp [Allemagne] ; T. Werfel [Allemagne]Therapy of noninfectious granulomatous skin diseases with fumaric acid esters
001E31 (2005) M. Worda ; C. S. Sreevidya [États-Unis] ; H. N. Ananthaswamy [États-Unis] ; L. Cerroni [Autriche] ; H. Kerl [Autriche] ; P. Wolf [Autriche]T1796A BRAF mutation is absent in Merkel cell carcinoma
001E34 (2005) J. Marcoval ; J. Ma A ; A. Moreno [Espagne] ; J. PeyriSubcutaneous sarcoidosis—clinicopathological study of 10 cases
001E77 (2005) J. Wenzel [Allemagne] ; S. Br Hler [Allemagne] ; R. Bauer [Allemagne] ; T. Bieber [Allemagne] ; T. Tüting [Allemagne]Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients
001E84 (2005) A. Mitra ; B. Pollock ; J. Gooi ; J. C. Darling ; A. Boon [Royaume-Uni] ; J. A. Newton-BishopCutaneous granulomas associated with primary immunodeficiency disorders
001F33 (2004) J. Kanitakis [France] ; S. Euvrard [France] ; A. C. Butnaru [France] ; A. Claudy [France]Verruciform xanthoma of the scrotum in a renal transplant patient
001F51 (2004) Y. Amo [Japon] ; M. Masuzawa [Japon] ; Y. Hamada [Japon] ; K. Katsuoka [Japon]Serum concentrations of vascular endothelial growth factor‐D in angiosarcoma patients
001F53 (2004) G. Dawn [Niger] ; S. C. Holmes [Niger]Scleromyxoedema‐like eruption following haemodialysis or nephrogenic fibrosing dermopathy?
001F61 (2004) P. Fiallo [Italie]Reduced therapeutic activity of warfarin during treatment with oral isotretinoin
001F74 (2004) News and Notices
001F77 (2004) I. Hayashi [Japon] ; T. Harada [Japon] ; M. Muraoka [Japon] ; M. Ishii [Japon]Malignant proliferating trichilemmal tumour and CAV (cisplatin, adriamycin, vindesine) treatment
001F79 (2004) A. Di Carlo [Italie]Lisinopril and Kaposi's sarcoma
001F80 (2004) N. Bilen [Turquie]Lisinopril and Kaposi's sarcoma: reply from authors
001F82 (2004) S. Yashar [États-Unis] ; K. F. Han [États-Unis] ; J. C. Haley [États-Unis]Lichen sclerosus–lichen planus overlap in a patient with hepatitis C virus infection
001F84 (2004) A. Macario-Barrel ; A. Zeghnoun ; P. Young ; L. Froment ; H. Levesque ; F. Caron [France] ; P. Musette ; P. JolyInfluence of environmental temperature on the occurrence of non‐necrotizing cellulitis of the leg
001F85 (2004) H. Haley ; W. Cantrell ; K. Smith [États-Unis]Infliximab therapy for sarcoidosis (lupus pernio)
001F92 (2004) Y-J. Deng [République populaire de Chine] ; F. Hao [République populaire de Chine] ; C-L. Zhou [République populaire de Chine] ; R-S. Sun [République populaire de Chine] ; M-M. Xiang [République populaire de Chine] ; J-W. Wang [République populaire de Chine] ; B-Y. Zhong [République populaire de Chine] ; Q-Y. Ye [République populaire de Chine] ; R-Q. Liu [République populaire de Chine]Generalized eruptive histiocytosis: a possible therapeutic cure?
001F95 (2004) G. Herrmann [Allemagne] ; L. Schneider [Allemagne] ; T. Krieg [Allemagne] ; N. Hunzelmann [Allemagne] ; K. Scharffetter-Kochanek [Allemagne]Efficacy of danazol treatment in a patient with the new variant of hereditary angio‐oedema (HAE III)
002002 (2004) Neil H. CoxDermatology – just the facts

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i -k "1365-2133" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i  \
                -Sk "1365-2133" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    ISSN.i
   |clé=    1365-2133
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021